[1] |
HOBIZAL KB,WUKICH DK.Diabetic foot infections:current concept review[J].Diabe Foot Ankle,2012,3(18):409-416.
|
[2] |
FORSYTHE RO,HINCHLIFFE RJ.Management of peripheral arterial disease and the diabetic foot[J]. J Cardiovasc Surg(Torino),2014,55(2 Suppl 1):195-206.
|
[3] |
张莹,王伟灵,杨沁彤,等.血清VCAM-1、FGF2等炎症因子与难愈性糖尿病足的相关性研究[J].检验医学,2014,29(5):472-476.
|
[4] |
DANIK JS,PARE G,CHASMAN DI,et al.Multiple novel loci,including those related to crohn's disease,psoriasis and inflammation, identified in a genome-wide association study of fibrinogen in 17,686 women: the women's genome health study[J].Circ Cardiovasc Genet,2009,2(2): 134-141.
|
[5] |
American Diabetes Association.Standards of medical care in diabetes-2011[J].Diabetes Care,2012,34(suppl 1):S11-S63.
|
[6] |
BAKKER K,APELQVIST J,SCHAPER NC,et al.Practical guidelines on the management and prevention of the diabetic foot 2011[J].Diabetes Metab Res Rev,2012,28(Suppl 1):225-231.
|
[7] |
WAGNER FW JR.The dysvascular foot:a system of diagnosis and treatment[J].Foot Ankle,1981,2(2):64-122.
|
[8] |
李积凤,王辰,王军.纤维蛋白原编码区SNP与血栓性疾病的关系及机制[J].首都医科大学学报,2010,31(5):559-562.
|
[9] |
朱平,任萌,徐刚,等.糖尿病周围神经病变和血管病变对糖尿病足溃疡的相互作用及相关性探讨[J].中国糖尿病杂志,2013,21(12):1074-1077.
|
[10] |
MESA MG,DUARTE HÁ,CARRETERO JH,et al.De Marco Formula effectiveness as an adjunctive therapy to prevent infected ischemic diabetic foot amputation and reduce plasma fibrinogen[J]. J Tissue Viability,2011,20(2):67-72.
|